Identification of Two <i>DNMT3A</i> Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia
Samantha Bruno(University of Bologna), Giovanni Martinelli(University of Bologna), Simona Soverini(University of Bologna), Anna Ferrari(University of Bologna), Andrea Ghelli Luserna di Rorà(Fondazione Pisa), Chiara Sartor(University of Bologna), Maria Chiara Fontana(Istituto Oncologico Romagnolo), Maria Chiara Abbenante(University of Bologna), Emanuela Ottaviani(University of Bologna), Giovanni Marconi(University of Bologna), Eugenia Franchini(University of Bologna), Maddalena Raffini(University of Bologna), Lorenza Bandini(University of Bologna), Cristina Papayannidis(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Giorgia Simonetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Antonella Padella(University of Bologna), Giovanna Prisinzano(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Claudia Venturi(University of Bologna), Maria Teresa Bochicchio(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Martina Pazzaglia(University of Bologna), Valentina Robustelli(University of Bologna)
Cited by 3
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644